EFFICACY AND SAFETY OF CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS VERSUS CONTINUED USE OF CALCINEURIN INHIBITORS IN RENAL ALLOGRAFT RECIPIENTS: 18-MONTH RESULTS FROM A RANDOMIZED, OPEN-LABEL COMPARATIVE TRIAL.

Francesco P Schena; Stephan Vitko; Ravinder Wali; Michael D Pascoe; Josefina Alberu; Maria del Carmen Rial

+ Author Information